fluconazole has been researched along with ENT Diseases in 2 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Naito, Y | 1 |
| Kikuchi, A | 1 |
| Funakubo, T | 1 |
| Kohsyu, H | 1 |
1 review available for fluconazole and ENT Diseases
| Article | Year |
|---|---|
[Emergent mycoses].
Topics: Amphotericin B; Antifungal Agents; beta-Glucans; Biomarkers; Disease Progression; Fatal Outcome; Flu | 2004 |
1 other study available for fluconazole and ENT Diseases
| Article | Year |
|---|---|
A study of fungal infections in otorhinolaryngology.
Topics: Adult; Aspergillosis; Aspergillus; Candida; Fluconazole; Humans; Japan; Male; Middle Aged; Mycoses; | 1994 |